← SynDRA
IPATASERTIB
SynDRA canonical compound SYN0034158 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | AKT2 |
|---|
| Mechanism of action | Akt inhibitor |
|---|
All known targets
- AKT1
- AKT2
- AKT3
- CYP3A5
- PRKG1
Mechanisms of action (all sources)
- AKT1 INHIBITOR
- AKT2 INHIBITOR
- Serine/threonine-protein kinase AKT inhibitor
- AKT3 INHIBITOR
Drug classes
- Antineoplastic Agents
- Protein Kinase Inhibitors
Cross-references
Synonyms
- RG-7440
- GDC-0068
- RG7440
- GDC 0068
- RG 7440
- GDC0068
- ipatasertibum
- RefChem:791216
- DTXCID301509858
- Ipatasertib (GDC-0068)
- MFCD22124514
- Ipatasertib; GDC-0068
- GDC-0068; Ipatasertib; RG 7440;
- Ipatasertib [INN]
- Ipatasertib [USAN:INN]
- UNII-524Y3IB4HQ
- C24H32ClN5O2
- GDC0068 di-HCl
- Ipatasertib (USAN/INN)
- IPATASERTIB [USAN]
- GDC-0068 di-HCl
- RG-7440 di-HCl
- IPATASERTIB [WHO-DD]
- SCHEMBL191659
- GTPL7887
- orb1300935
- SCHEMBL29356998
- CHEBI:95089
- GRZXWCHAXNAUHY-NSISKUIASA-N
- GLXC-90195
- EX-A2077
- BDBM50398379
- NSC767898
- NSC781451
- NSC800986
- NSC832484
- s2808
- AKOS025396463
Look up IPATASERTIB in the interactive SynDRA portal →